Medical Properties Trust director awarded 30,303 MPW shares

Medical Properties Trust director reports stock award Director Thompson C. Reynolds III reported receiving 30,303 shares of Medical Properties Trust common stock on January 8, 2026.

Rhea-AI Filing Summary

Medical Properties Trust director reports stock award

Director Thompson C. Reynolds III reported receiving 30,303 shares of Medical Properties Trust common stock on January 8, 2026. The reported price of $0 per share indicates this was an equity award rather than an open-market purchase. Following this grant, he beneficially owns 108,795 shares, held directly.

The award is structured to vest over time. According to the filing, the shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, aligning director compensation with the company’s longer-term performance.

Insider Trade Summary

Grant/Award: 30,303 shares

Grant/Award 1 txn

Insider THOMPSON C REYNOLDS III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	30,303	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 108,795 shares (Direct)

Footnotes (1)

1. F1. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MPW disclose for Thompson C. Reynolds III?

The filing shows that director Thompson C. Reynolds III received an award of 30,303 shares of Medical Properties Trust common stock on January 8, 2026.

At what price were the MPW shares awarded to the director?

The 30,303 shares of Medical Properties Trust common stock were reported at a price of $0 per share, indicating a stock-based compensation award.

How many MPW shares does the director own after this transaction?

After the reported award, Thompson C. Reynolds III beneficially owns 108,795 shares of Medical Properties Trust common stock, held directly.

How do the awarded MPW shares vest for the director?

The filing states that the awarded shares vest ratably at the beginning of each of the 12 calendar quarters starting on April 1, 2026.

Is Thompson C. Reynolds III a 10% owner of Medical Properties Trust (MPW)?

No. The filing identifies him as a director of Medical Properties Trust and does not mark him as a 10% owner.

Is the MPW director’s stock award held directly or indirectly?

The 108,795 shares beneficially owned following the award are reported with an ownership form of Direct (D), indicating direct ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

THOMPSON C REYNOLDS III

(Last) (First) (Middle)

1000 URBAN CENTER DRIVE

SUITE 501

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	01/08/2026		A		30,303(1)	A	$0	108,795	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2026.

	W. Zachary Riddle, by power of attorney	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.